OOIR: Observatory of International Research

Papers

(The H4-Index of Brain is 73. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Correction to: Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders	441
Source-sink connectivity: a novel interictal EEG marker for seizure localization	302
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models	261
The RAB3A hot spot variant R83W causes spasticity as part of the ataxia-spasticity spectrum	230
Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline	222
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1	219
Optogenetic stimulation of the superior colliculus suppresses genetic absence seizures	211
Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder	210
Deep brain stimulation: a tale of two targets … and closing the loop	207
Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism	196
We’re all in this together: a rejoinder to Masud Husain’s (rant) editorial	190
Genetically identical twin-pair difference models support the amyloid cascade hypothesis	186
Thalamic stereo EEG: a clinically justified extension of hypothesis-driven intracranial exploration	177
Reply: Is postural tachycardia syndrome a psychogenic disorder?; Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome; Patients with POTS fear that data o	172
The axon initial segment as a source of neuropathic pain	162
Methodological drawbacks in the alleged association between foetal sonographic anomalies and autism	157
Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations	156
Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation	152
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum	151
Dysfunction of the magnocellular subdivision of the visual thalamus in developmental dyslexia	150
In vivo self-assembled siRNAs ameliorate neurological pathology in TDP-43-associated neurodegenerative disease	147
Lesion correlates of impaired acoustic-phonetic perception after unilateral left hemisphere stroke	139
Maternal microbiome-derived propionate regulates offspring myelination via histone lactylation	136
Global network and local vulnerabilities underlie brain atrophy across Parkinson’s disease stages	134
De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features	134

Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins	133
Thalamostriatal disconnection underpins long-term seizure freedom in frontal lobe epilepsy surgery	132
The vascular contribution of apolipoprotein E to Alzheimer’s disease	129
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development	124
Dopamine and the dynamics of subthalamic and leg muscle activities in parkinsonian stepping	122
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease	120
‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy	120
Apathy, effort-based decisions and brain integrity in Alzheimer's and Parkinson's diseases	114
The inferior fronto-occipital fasciculus: bridging phylogeny, ontogeny and functional anatomy	113
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine	112
Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults	110
From bugs to brain: unravelling the GABA signalling networks in the brain–gut–microbiome axis	108
Mapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing	107
The use of optical coherence tomography in neurology: a review	106
Speech and language markers of neurodegeneration: a call for global equity	104
Brain repair mechanisms after cell therapy for stroke	104
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes	99
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression	99
Correction to: New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy	98
Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40	97
Normalization of network activity in an epilepsy model with a constitutively active GABBR2 variant	96
Distinct contribution of spinal neuropeptide Y and NPY1R neurons to morphine analgesia	94
Loss of DOT1L disrupts neuronal transcription and leads to a neurodevelopmental disorder	94
Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability	94
Demystifying interictal discharges and seizure initiation in focal epilepsy	93
The low dimensionality of post-stroke cognitive deficits: it’s the lesion anatomy!	93
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease	92
Loss-of-function variants inMYCBP2cause neurobehavioural phenotypes and corpus callosum defects	91
How COVID-19 affects microvessels in the brain	86
Clinical features and prognostic factors in adults with brain abscess	85
Neural stem cell therapies for spinal cord injury repair: an update on recent preclinical and clinical advances	85
New mechanistic insights into hereditary spastic paraplegias	84
Extra-cranial cholinergic lesions in dementia with Lewy bodies	84
Preclinical type 2 diabetes mellitus subtypes: new insights into diabetes, depression and dementia	82
Disruption of DNA methylation underpins the neuroinflammation induced by targeted CNS radiotherapy	81
Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1–ADAM22/23 pathway	81
Evolutionary perspectives on mRNA signatures of neurodegeneration-related brain remodelling	80
The interictal suppression hypothesis is the dominant differentiator of seizure onset zones in focal epilepsy	80
Cytotoxic T cells and plasma cells dominate early in temporal lobe epilepsy with GAD antibodies	80
That which we call cortisol awakening response, by any other word would smell as sweet	79
Integrative miRNA–mRNA profiling of human epidermis: unique signature of SCN9A painful neuropathy	76
Cross-seeding by prion protein inactivates TDP-43	76
Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy	75
Defective lipid signalling caused by mutations inPIK3C2Bunderlies focal epilepsy	75
Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence	75
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults	74
Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit	74
Is glymphatic clearance the secret to restorative sleep?	74
Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology	73
Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis	73